Alpha Centric Advisors LLC Gsk PLC Transaction History

Alpha Centric Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Mar 09, 2022	SELL	$36.52 - $41.46 $365,200 - $414,600	-10,000 Closed	0 $0
Q1 2021 Mar 09, 2022	BUY	$34.27 - $40.01 $270,733 - $316,079	7,900 Added 376.19%	10,000 $357,000
Q4 2020 Mar 11, 2022	BUY	$34.07 - $39.94 $64,733 - $75,886	1,900 Added 950.0%	2,100 $77,000
Q2 2020 Mar 11, 2022	BUY	$37.87 - $43.58 $7,573 - $8,716	200 New	200 $8,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.1B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Centric Advisors LLC with notifications on news.